Naloxone

The Court Services and Offender Supervision Agency (CSOSA) is seeking to procure 450 Naloxone 2-dose nasal spray packages, each containing 4 MG of Naloxone HCL in 0.1 ML, through a competitive small business solicitation. The contract, numbered 9594CS25Q0020, requires delivery within 30 days of award to CSOSA's Washington, DC location, with contractors required to provide 7-day advance delivery notification. Quotations are due by January 7, 2025, at 2:00 PM EST and must be submitted via email to matthew.collins@csosa.gov. The agency will evaluate quotes based on the lowest price from a responsible quoter who meets all solicitation requirements, with a firm-fixed price purchase order structure. Contractors must complete comprehensive representations and certifications, including details about their business status, compliance with federal regulations, and submission of required documentation.

The solicitation is exclusively set aside for small businesses within the Pharmaceutical Preparation Manufacturing NAICS code 325412, with a size standard of 1,300 employees. Payment for the contract will be processed through the Invoice Processing Platform (IPP) system, with the Interior Business Center - FMD serving as the "Bill to Agency". Contractors must provide detailed information including their company name, business address, point of contact, tax identification number, unique entity identifier, and CAGE code. The contract requires signed copies of the SF1449 and all amendments, with quotes remaining valid for 30 days. Manufacturers must also submit their company details, including business address and phone number, as part of the submission requirements. The total contract value is not explicitly stated, but the procurement involves 450 units of Naloxone nasal spray packages to be delivered to Washington, DC.